Bioengineering Consultants, Ltd.
Country not established
- Devices
- 1
What Bioengineering Consultants, Ltd. makes
Bioengineering Consultants, Ltd. manufactures the K-C Hemostatic Biopsy System, a device designed for controlling bleeding during biopsy procedures by applying localized pressure and hemostatic agents to the wound site.
The K-C Hemostatic Biopsy System is classified as a Class II medical device in the U.S. and is listed under the FDA’s 510(k) pathway. The company is based in the United States.
Catalogue
K-C Hemostatic Biopsy System Ref K050135
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Bioengineering Consultants, Ltd. have in the registry?
The registry currently lists 1 device for Bioengineering Consultants, Ltd.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Bioengineering Consultants, Ltd.'s devices?
Among its 1 most recently registered device, Bioengineering Consultants, Ltd. has devices listed in FDA 510(k) (1 device).
What risk classes do Bioengineering Consultants, Ltd.'s devices fall under?
Among its 1 most recently registered device, the classes recorded for Bioengineering Consultants, Ltd.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Bioengineering Consultants, Ltd. in the registry?
The most recently registered devices listed for Bioengineering Consultants, Ltd. include K-C HEMOSTATIC BIOPSY SYSTEM.